Speedata, whose first-of-its-kind Analytics Processing Unit (APU) is designed to accelerate big data analytic workloads across industries, has announced the results of a simulation of its APU on a compound similarity analysis workload in the pharmaceutical industry. Using the APU, the analysis was completed in 19 minutes, compared to 90 hours when using a CPU…

Proscia, a provider of digital and computational pathology solutions, has announced that Virscio, a provider of translational research and development services, has deployed Concentriq for Research. The contract research organization (CRO) is leveraging Proscia’s flagship software platform to provide faster, more informed drug safety insights, helping its sponsors to improve research and development (R&D) efficiency.…

By Jesse Harris, Digital Marketing Coordinator, ACDLabs In September 2019 the FDA learned that the common heartburn products Zantac and Axid contained elevated levels of the carcinogen N-nitrosodimethylamine (NDMA). Ranitidine and nizatidine, the active ingredients in these medications, appeared to be the source of this impurity. By April 1, 2020, the FDA asked that all…

Thermo Fisher Scientific is adding early development work for oral solid dose therapies to its Bourgoin, France site, enabling that location to address customers’ workflow from early drug development through commercial manufacturing and underscoring the company’s commitment to helping clients get medicines to patients sooner. “In the last decade, Thermo Fisher has led and advanced…

Thermo Fisher Scientific and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult-to-treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus. The partnership between Thermo Fisher and UCSF, first announced in 2021, has the potential to demonstrate…

Waters Corporation introduces Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting, and ease of use. When combined with Waters’ compliance-ready Empower Chromatography Software and eConnect HPLC Columns, the Alliance iS High Performance Liquid Chromatography (HPLC) System streamlines the task of making accurate…

Proscia, a provider of digital and computational pathology solutions, has strengthened its position in the $12 billion[1] preclinical R&D market. At the center of its expansion, the company is enhancing its flagship Concentriq for Research, trusted by 14 of the top 20 pharmaceutical companies as a singular software platform for pathology workflows and data, to…

From Purdue University Surgery, especially surgery to remove cancerous tumors, relies on a range of tools and techniques as well as on the skill of the surgeon. Now, new imaging agent Cytalux will make surgery to remove lung cancer tumors a little more exact. The inside of the human body famously looks nothing like an…

ViroStat has just released its new catalog of infectious disease antibodies and antigens. This newest release includes 790 antibodies for use in antigen detection assays such as lateral flow rapid tests, ELISA, IFA, and CLIA. Many recommended pairs are available. Infectious targets include viruses, bacteria, toxins, parasites, and fungi. Go to the ViroStat website www.virostat-inc.com…

By Christian Olsen, Business Segment Lead, Dotmatics Biologic drugs have increasingly delivered treatments for cancer and rare diseases and continue to prove effective in other wide-ranging areas, from neurological and metabolic disorders to respiratory and cardiovascular diseases. But along with the incredible potential biologics offer, there is also great pressure to discover and deliver novel…

By Haydn Boehm, Director of Product Marketing, Dotmatics Despite the buzz around artificial intelligence (AI), most industry insiders know that the use of machine learning (ML) in drug discovery is nothing new. For more than a decade, researchers have used computational techniques for many purposes, such as finding hits, modeling drug-protein interactions, and predicting reaction…

Nortis is an innovator in the rapidly emerging Organ-on-Chip (OOC) field, which enables the engineering of living human tissues in microfluidic devices (chips). These chips are highly valuable for both pharma and academia, both of which are looking for novel technologies that will enable them to move away from animal models to improve drug development…

Dotmatics, a maker of R&D scientific software that connects science, data and decision-making, announces the release of its Small Molecule Drug Discovery Solution, an integrated scientific R&D platform with pre-configured workflows and expanded data management capabilities. The solution helps companies innovate more easily and expedites time to deployment by leveraging best practices derived from the…

If 2020 underscored the importance of the pharma industry’s social importance, 2021 demonstrated the industry’s ability to translate R&D into profitable commercialized products. But while strong demand for COVID-19 therapies in 2021 provided unprecedented revenue levels for a handful of Big Pharma companies, it didn’t result in substantial changes in R&D spending.  (Look out for…

Two Rutgers engineers specializing in the process of making drugs derived from living organisms have created an analytical tool they expect will accelerate the discovery and production of biologic drugs that are often at the cutting edge of biomedical research. In an article that is the cover story in the American Chemical Society journal, Analytical…

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a science and technology company, has announced that its ZooMAb recombinant antibodies platform earned Accountability, Consistency and Transparency (ACT) label from My Green Lab, a non-profit organization dedicated to creating a culture of sustainability in science. The first-ever antibody to achieve ACT…

By Rob Taylor, Pharmaceutical Segment Manager, Malvern Panalytical Sometimes you must take things apart to rebuild them. For a child with a LEGO masterpiece, this can be heartbreaking. But in the world of pharmaceuticals, reverse-engineering drugs is crucial for the development of less expensive, more accessible generic products. Chemical and structural reverse engineering, also known…

PerkinElmer. will be at The American Association for Cancer Research (AACR) Annual Meeting from April 8-13 in New Orleans (booths #1009, #1851 and #909), alongside its partner companies showcasing how genomic and cellular solutions for cancer research can be used to study its mechanisms, improve biomarker discovery, and help drive targeted, therapeutic discovery leading to…

Sepha, the Northern Ireland-based manufacturer of pharmaceutical packaging and equipment, has developed a new compact small-batch blister packaging machine with full traceability and electronic data storage capabilities. The EZ Blister+ meets increased demand for 21 CFR Part 11 compliant micro-batches throughout the blister production lifecycle, from R&D right through to commercial production. It will launch…

Certara’s COVID-19 Vaccine Model allows researchers to study how a vaccine is handled by the human body in computer-generated, virtual populations. It uses biosimulation (computer-aided modeling and simulation integrated with pharmaceutical and biological science) to generate virtual populations with different ages, gender, weight, genetics, diet, illnesses and medications. It can then efficiently run virtual clinical…

GenNext Technologies, a growth-stage company providing biopharmaceutical drug discovery systems and services, announced the receipt of a two year, Phase II SBIR grant for a project titled “In-Cell Automated Flash Oxidation (IC-AutoFox) Protein Footprinting System.” The grant was awarded by the National Institute of General Medical Systems (NIGMS) of the U.S. Department of Health and…

Genomenon Inc., an AI-driven genomics company, announces the completion of a $20 million Series B financing round. The funds will expand the company’s commercial operations and the development of its genomic data hub, which serves genetic testing labs, hospitals, pharmaceutical, and biopharma companies. Genomenon leverages AI (Artificial Intelligence) to organize the world’s genomic knowledge and…

The R&D World Index (RDWI) for the week ending March 4, 2022, closed at 5,058.27 for the 25 companies in the RDWI. The Index was down 2.21% (or 114.22 basis points) from the week ending February 25, 2022. The stock of 10 RDWI members gained value from 0.18% (Oracle) to 4.79% (Eli Lilly & Co.).…

Thermo Fisher Scientific and Symphogen, an affiliate of the pharmaceutical company Servier, announce the continuation of their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterization of complex therapeutic proteins. Since the collaboration began in 2018, Symphogen has adopted new and innovative instruments and software to improve…

Holographyx has recently been granted a U.S. patent for its Holo-Blister product along with a European Patent for the development of this cost-effective method to apply holograms to the back of blister packs using conventional heat-seal blister packaging equipment. Holo-Blister holograms have been designed so that they will only be visible behind each pill/capsule cavity…